Sumeet Gujral

Primary diffuse large B‐cell lymphoma of the tonsil

Siddhartha Laskar, Gaurav Bahl, Mary Ann Muckaden et al. · Cancer · 2007 · 94 citations · Full text

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)

Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh et al. · Leukemia · 2021 · 92 citations · Full text

Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma

Robert Carr, Stefano Fanti, Diana Páez et al. · Journal of Nuclear Medicine · 2014 · 76 citations · Full text

A High‐Sensitivity 10‐Color Flow Cytometric Minimal Residual Disease Assay in B‐Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2‐in‐10⁶and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients

Prashant Tembhare, Papagudi Ganesan Subramanian, Sitaram Ghogale et al. · Cytometry Part B Clinical Cytometry · 2019 · 74 citations · Full text

Combined PET and Biopsy Evidence of Marrow Involvement Improves Prognostic Prediction in Diffuse Large B-Cell Lymphoma

Juliano J. Cerci, Tamás Györke, Stefano Fanti et al. · Journal of Nuclear Medicine · 2014 · 71 citations · Full text